ALPN - Alpine Immune Sciences, Inc.

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
Get access to 40+ years of historical data with Yahoo Finance Premium.Learn more
Currency in USD

Valuation Measures

Premium required to access annual data
Premium required to access monthly data
Subscribe to Premium to download historical data
As of Date: 6/1/2020
Market Cap (intraday) 5
Enterprise Value 3
Trailing P/E
Forward P/E 1
PEG Ratio (5 yr expected) 1
Price/Sales (ttm)
Price/Book (mrq)
Enterprise Value/Revenue 3
Enterprise Value/EBITDA 6

Trading Information

Stock Price History

Beta (5Y Monthly) 2.33
52-Week Change 3-4.66%
S&P500 52-Week Change 38.32%
52 Week High 35.3500
52 Week Low 32.0500
50-Day Moving Average 33.2706
200-Day Moving Average 33.1799

Share Statistics

Avg Vol (3 month) 318.57k
Avg Vol (10 day) 336.31k
Shares Outstanding 518.59M
Float 3.96M
% Held by Insiders 140.52%
% Held by Institutions 144.39%
Shares Short (May 14, 2020) 48.68k
Short Ratio (May 14, 2020) 40.62
Short % of Float (May 14, 2020) 40.17%
Short % of Shares Outstanding (May 14, 2020) 40.05%
Shares Short (prior month Apr 14, 2020) 48.31k

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 21:4
Last Split Date 3Jul 24, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 30, 2018
Most Recent Quarter (mrq)Sep 29, 2019


Profit Margin 0.00%
Operating Margin (ttm)-5,607.71%

Management Effectiveness

Return on Assets (ttm)-46.42%
Return on Equity (ttm)-104.32%

Income Statement

Revenue (ttm)856k
Revenue Per Share (ttm)0.05
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-34.11M
EBITDA -47.55M
Net Income Avi to Common (ttm)-46.85M
Diluted EPS (ttm)-2.7280
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)46.59M
Total Cash Per Share (mrq)2.51
Total Debt (mrq)16.24M
Total Debt/Equity (mrq)46.61
Current Ratio (mrq)3.84
Book Value Per Share (mrq)1.87

Cash Flow Statement

Operating Cash Flow (ttm)-39.07M
Levered Free Cash Flow (ttm)-22.3M